OVIT (OncoVista Innovative Therapies) OCF Margin %: 0.00% (As of Sep. 2015)


What is OncoVista Innovative Therapies OCF Margin %?

OncoVista Innovative Therapies OVIT OCF Margin % is 0.00% as of Sep. 2015.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. OncoVista Innovative Therapies's Cash Flow from Operations for the three months ended in Sep. 2015 was $-0.03 Mil. OncoVista Innovative Therapies's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, OncoVista Innovative Therapies's OCF Margin % for the quarter that ended in Sep. 2015 was 0.00%.

As of today, OncoVista Innovative Therapies's current OCF Yield % is -13,200.00%.

The historical rank and industry rank for OncoVista Innovative Therapies's OCF Margin % or its related term are showing as below:


OVIT's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

OncoVista Innovative Therapies OCF Margin % Related Terms

OncoVista Innovative Therapies OCF Margin % Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies OCF Margin % Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

OncoVista Innovative Therapies's OCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-0.232/0
= %

OncoVista Innovative Therapies's OCF Margin for the quarter that ended in Sep. 2015 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2015 )/Revenue (Q: Sep. 2015 )
=-0.027/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
OncoVista Innovative Therapies (OVIT) has a OCF Margin % of 0.00% as of Sep. 2015. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' OCF Margin % too high?
OncoVista Innovative Therapies' current OCF Margin % is 0.00%.
How does OncoVista Innovative Therapies' OCF Margin % compare to RSPI and HSTC?
OncoVista Innovative Therapies' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current OCF Margin % is 0.00% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.